Navigation Links
How shyness and other normal human traits became sickness
Date:10/10/2007

What's wrong with being shy, and just when and how did bashfulness and other ordinary human behaviors in children and adults become psychiatric disorders treatable with powerful, potentially dangerous drugs, asks a Northwestern University scholar in a new book that already is creating waves in the mental health community.

In "Shyness: How Normal Behavior Became a Sickness" (Yale University Press, October 2007), Northwestern's Christopher Lane chronicles the "highly unscientific and often arbitrary way" in which widespread revisions were made to "The Diagnostic and Statistical Manual of Mental Disorders" (DSM), a publication known as the bible of psychiatry that is consulted daily by insurance companies, courts, prisons and schools as well as by physicians and mental health workers.

(Note to Chicago editors: Lane will launch his book with a free, public talk hosted by the Chicago Psychoanalytic Society at 7:30 p.m. Tuesday, Oct. 23, at National Lewis University, 122 S. Michigan Ave., Room 5006, Chicago.)

"The number of mental disorders the general population might exhibit leaped from 180 in 1968 to more than 350 in 1994," notes Lane, Northwestern's Herman and Beulah Pearce Miller Research Professor. In a book that calls into doubt the facade of objective research behind psychiatry's revolution, Lane questions the rationale for the changes, and whether all of them were necessary and suitably precise.

By labeling shyness and other human traits as mental conditions with a biological cause, the doors were opened wide to a pharmaceutical industry ready to provide a pill for every alleged chemical imbalance or biological problem, the author says.

Lane, who meticulously and systematically researched the archives of the American Psychiatric Association, uses social anxiety disorder (first dubbed social phobia) as the lens through which to analyze American psychiatry's extraordinary shift in the last 30 years from a psychoanal
'/>"/>

Contact: Wendy Leopold
w-leopold@northwestern.edu
847-491-4890
Northwestern University
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Shyness Linked To HIV Progression
2. Shed Off Your Shyness With a Nasal Spray!
3. Another ray of hope for Arthritis Sufferers
4. Another injectable contraceptive Pill approved by FDA
5. Endangered species may be successfully cloned in another animals womb
6. Acupuncture May Help Chemotherapy Side Effects
7. Spouses and other partners lower blood pressure says new research
8. Yet Another Harmful Consequence Of Smoking
9. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
10. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
11. Radiotherapy helps in colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 1NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 2NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 3Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 1Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4